Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stereotactic Ablative Radiotherapy”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Testing effectiveness (Phase 2)UnknownNCT01565837
What this trial is testing

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

Who this might be right for
Melanoma
Wolfram Samlowski 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Not applicableLooking for participantsNCT05679427
What this trial is testing

Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions

Who this might be right for
Oligometastatic Disease
IRCCS San Raffaele 307
Not applicableStudy completedNCT03160794
What this trial is testing

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

Who this might be right for
Post Prostatectomy
University Health Network, Toronto 150
Large-scale testing (Phase 3)Looking for participantsNCT02468024
What this trial is testing

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center 272
Testing effectiveness (Phase 2)UnknownNCT01825824
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

Who this might be right for
Hepatocellular Carcinoma
Korea Cancer Center Hospital 54
Not applicableLooking for participantsNCT06560697
What this trial is testing

Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma

Who this might be right for
Uterine Cervical Neoplasm
National Institute of Cancerología 84
Testing effectiveness (Phase 2)Looking for participantsNCT06835725
What this trial is testing

Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CA
British Columbia Cancer Agency 100
Not applicableActive Not RecruitingNCT05830838
What this trial is testing

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

Who this might be right for
Malignant Prostate Neoplasm
Mayo Clinic 50
Not applicableLooking for participantsNCT07407608
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca 58
Not applicableLooking for participantsNCT02016248
What this trial is testing

SBRT Boost for Unfavorable Prostate Cancer'

Who this might be right for
Prostate Cancer
MemorialCare Health System 150
Large-scale testing (Phase 3)Looking for participantsNCT05815927
What this trial is testing

Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

Who this might be right for
Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC 200
Testing effectiveness (Phase 2)UnknownNCT01823003
What this trial is testing

Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Institut Català d'Oncologia 67
Testing effectiveness (Phase 2)Looking for participantsNCT05657873
What this trial is testing

Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon-small Cell Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04045717
What this trial is testing

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

Who this might be right for
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Universitaire Ziekenhuizen KU Leuven 124
Large-scale testing (Phase 3)UnknownNCT05111197
What this trial is testing

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Who this might be right for
Locally Advanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Institut Cancerologie de l'Ouest 112
Early research (Phase 1)Study completedNCT02599454
What this trial is testing

Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Stage I Non-Small Cell Lung Cancer
Megan Daly, MD 20
Not applicableActive Not RecruitingNCT02933242
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Who this might be right for
Metastatic Tumors
British Columbia Cancer Agency 399
Large-scale testing (Phase 3)Looking for participantsNCT06320067
What this trial is testing

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University College, London 3,360
Not applicableStudy completedNCT05283564
What this trial is testing

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

Who this might be right for
Lung Cancer
Stanford University 25
Next Page